Cargando…
Intermediate phenotypes and biomarkers of treatment outcome in major depressive disorder
Major depressive disorder (MDD) is a pleomorphic illness originating from gene x environment interactions. Patients with differing symptom phenotypes receive the same diagnosis and similar treatment recommendations without regard to genomics, brain structure or function, or other physiologic or psyc...
Autores principales: | Leuchter, Andrew F., Hunter, Aimee M., Krantz, David E., Cook, Ian A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Les Laboratoires Servier
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4336921/ https://www.ncbi.nlm.nih.gov/pubmed/25733956 |
Ejemplares similares
-
Time Course of Changes in Peripheral Blood Gene Expression During Medication Treatment for Major Depressive Disorder
por: Cook, Ian A., et al.
Publicado: (2019) -
Concomitant medication use and clinical outcome of repetitive Transcranial Magnetic Stimulation (rTMS) treatment of Major Depressive Disorder
por: Hunter, Aimee M., et al.
Publicado: (2019) -
A new paradigm for the prediction of antidepressant treatment response
por: Leuchter, Andrew F., et al.
Publicado: (2009) -
The relationship between brain oscillatory activity and therapeutic effectiveness of transcranial magnetic stimulation in the treatment of major depressive disorder
por: Leuchter, Andrew F., et al.
Publicado: (2013) -
Repetitive transcranial magnetic stimulation treatment of major depressive disorder and comorbid chronic pain: response rates and neurophysiologic biomarkers
por: Corlier, Juliana, et al.
Publicado: (2023)